"By providing deeper insights into cellular interactions, our instruments empower researchers to make faster, better-informed decisions, with the goal of improving success rates in clinical trials and accelerating the development of effective therapies," said the company's CEO Hugo de Wit.
Lumicks' tech allows scientists to gather real-time data on the bonds between immune cells and cancer cells. Unlike traditional methods, which rely on indirect biomarkers, the analyser precisely measures the actual strength and duration of those interactions directly and in real time.
Collection
[
|
...
]